MGC Pharmaceuticals Health Care
Biotech Cannabis Healthcare Pharmaceuticals

$0.005 (0%)

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code MXC	Name MGC Pharmaceuticals Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date 2006-12-15	Fiscal Year June	Type Common Stock
Shares Outstanding 43,851,600	Shares Floated 20,860,441	Held by Insiders 8.166%	Held by Institutions 1.243%

Directors & Officers

Name & Education	Position
Mr. Roby Reuven Zomer	Co-Founder, CEO, MD & Executive Director
Mr. Tom Cairns	Chief Accounting Officer
Ms. Yifat Steuer	Deputy CEO & COO
Ms. Nicole Ann Godresse	Global Chief Sales Officer
Mr. Amir Polak	Chief Pharmaceutical Development Officer
Ms. Sabina Suljakovic	Head of the Quality Assurance Department
Dr. Nadya Lisovoder	Chief Medical Officer
Ms. Sasha Friedman	Deputy CEO
Yair Tal	Chief Information Security Officer
Mr. Robert Clements	Chief Commercial Officer

MXC Historic Dividends

Date	Amount
We found no dividends on record for MXC.

End of Day Prices

Date	Close	Volume	Change
29-Apr	$0.42	6,035	0.00 (0.00%)
26-Apr	$0.42	1,033	+0.01 (2.47%)
24-Apr	$0.41	6,603	-0.03 (5.81%)
23-Apr	$0.43	0	0.00 (0.00%)
22-Apr	$0.43	5,109	0.00 (0.00%)
19-Apr	$0.43	4,257	0.00 (0.00%)
18-Apr	$0.43	0	0.00 (0.00%)
17-Apr	$0.43	2	-0.01 (1.15%)
16-Apr	$0.44	18,828	-0.01 (2.25%)
15-Apr	$0.45	11,403	0.00 (0.00%)
12-Apr	$0.45	49,208	+0.01 (2.30%)
11-Apr	$0.44	8,542	+0.02 (4.82%)
10-Apr	$0.42	6,145	-0.02 (3.49%)
09-Apr	$0.43	43,411	+0.02 (3.61%)
08-Apr	$0.42	27,077	+0.01 (1.22%)
5 up, 4 down, and 6 flat days

Market Cap (29-Apr) $18,417,672	EBITDA -	PE 14.90	Book Value $0.04
Dividend per Share N/A	Dividend Yield N/A	EPS $-3.21	Profit Margin N/A
Operating Margin -1343.42%	ROA 58.96%	ROE 307.4%	Revenue (FY) $1,324,457
Revenue per Share $0.10	Gross Profit (FY) $1,286,462	Q' YOY Revenue Growth 77.5%	Q' YOY Earnings Growth -

MGC Pharmaceuticals Health Care
Biotech Cannabis Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2023)

Directors & Officers

MXC Historic Dividends

Followers

Prices

Announcements

End of Day Prices

MGC Pharmaceuticals Health Care Biotech Cannabis Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2023)

Directors & Officers

MXC Historic Dividends

Followers

Prices

Announcements

End of Day Prices

MGC Pharmaceuticals Health Care
Biotech Cannabis Healthcare Pharmaceuticals